Compare ECOR & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | HCAT |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.3M | 118.9M |
| IPO Year | 2018 | 2019 |
| Metric | ECOR | HCAT |
|---|---|---|
| Price | $9.62 | $1.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $19.17 | $1.77 |
| AVG Volume (30 Days) | 79.7K | ★ 425.5K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $32,032,000.00 | ★ $311,136,000.00 |
| Revenue This Year | $30.85 | N/A |
| Revenue Next Year | $29.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | 1.48 |
| 52 Week Low | $4.41 | $0.96 |
| 52 Week High | $12.70 | $3.62 |
| Indicator | ECOR | HCAT |
|---|---|---|
| Relative Strength Index (RSI) | 40.72 | 51.40 |
| Support Level | $8.63 | $1.67 |
| Resistance Level | $9.53 | $1.89 |
| Average True Range (ATR) | 0.61 | 0.07 |
| MACD | -0.24 | 0.00 |
| Stochastic Oscillator | 4.71 | 42.97 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.